THE DIAGNOSIS OF LIVER-DISEASES BY LABORATORY TESTS - AN ALTERNATIVE TO BIOPSY

被引:1
作者
COLLAZOS, J
机构
[1] Servicio de Medicina Interna, Hospital de Galdakao, Vizcaya
关键词
LIVER BIOPSY; LIVER DISEASES; LIVER FUNCTION TESTS; CIRRHOSIS; FIBROSIS; PATIENTS CARE;
D O I
10.1097/00004836-199510000-00002
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Liver biopsy is still the most reliable procedure for the diagnosis of chronic, diffuse liver disease, so it is performed routinely to elucidate chronic alterations of liver tests. However, expensive and invasive, it is not exempt from risk and has limitations due to sampling error and to the size and quality of the tissue obtained. Moreover, many patients who undergo liver biopsy get no further treatment or do not benefit from treatment when the biopsy results are known. In addition, new biochemical tests have been developed in recent years as noninvasive tools to diagnose liver diseases, particularly fibrosis and cirrhosis. Thus, the role of liver biopsy in the improvement of outcome and quality of life of patients with chronic, diffuse liver diseases should be reconsidered. Many liver biopsies might well be avoided with the rational use of these noninvasive methods: without any deleterious effect on patient care. Current tests and future developments in this field should help us to select those patients who would best benefit from a liver biopsy.
引用
收藏
页码:176 / 178
页数:3
相关论文
共 14 条
[1]   ADVANCES IN DIAGNOSTIC-IMAGING AND OVERESTIMATIONS OF DISEASE PREVALENCE AND THE BENEFITS OF THERAPY [J].
BLACK, WC ;
WELCH, HG .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (17) :1237-1243
[2]  
CHUAH SY, 1992, GUT, V33, P16
[3]   COMPLICATIONS OF PERCUTANEOUS LIVER-BIOPSY IN CHILDREN [J].
COHEN, MB ;
AKADER, HH ;
LAMBERS, D ;
HEUBI, JE .
GASTROENTEROLOGY, 1992, 102 (02) :629-632
[4]  
DESMET VJ, 1990, ACTA GASTRO-ENT BELG, V53, P198
[5]   PRACTICE AND COMPLICATIONS OF LIVER-BIOPSY - RESULTS OF A NATIONWIDE SURVEY IN SWITZERLAND [J].
FROEHLICH, F ;
LAMY, O ;
FRIED, M ;
GONVERS, JJ .
DIGESTIVE DISEASES AND SCIENCES, 1993, 38 (08) :1480-1484
[6]   OUTPATIENT LIVER-BIOPSY - HOW SAFE IS IT [J].
GARCIATSAO, G ;
BOYER, JL .
ANNALS OF INTERNAL MEDICINE, 1993, 118 (02) :150-152
[7]   OUTCOME OF PATIENTS HOSPITALIZED FOR COMPLICATIONS AFTER OUTPATIENT LIVER-BIOPSY [J].
JANES, CH ;
LINDOR, KD .
ANNALS OF INTERNAL MEDICINE, 1993, 118 (02) :96-98
[8]  
KROPF J, 1988, CLIN CHEM, V34, P2026
[9]   TISSUE INHIBITOR OF METALLOPROTEINASE IS INCREASED IN THE SERUM OF PRECIRRHOTIC AND CIRRHOTIC ALCOHOLIC PATIENTS AND CAN SERVE AS A MARKER OF FIBROSIS [J].
LI, JJ ;
ROSMAN, AS ;
LEO, MA ;
NAGAI, Y ;
LIEBER, CS .
HEPATOLOGY, 1994, 19 (06) :1418-1423
[10]   SERUM TYPE-III PROCOLLAGEN PEPTIDE, TYPE-IV COLLAGEN 7S DOMAIN, CENTRAL TRIPLE-HELIX OF TYPE-IV COLLAGEN AND TISSUE INHIBITOR OF METALLOPROTEINASES IN PATIENTS WITH CHRONIC VIRAL LIVER-DISEASE - RELATIONSHIP TO LIVER HISTOLOGY [J].
MURAWAKI, Y ;
IKUTA, Y ;
KODA, M ;
KAWASAKI, H .
HEPATOLOGY, 1994, 20 (04) :780-787